Turkey: A decade-long study from a tertiary care hospital highlights the effectiveness and safety of narrow-band ultraviolet ...

Announcing a new publication for Acta Materia Medica journal. Phosphodiesterase-4 (PDE4), a member of the phosphodiesterase ...

Trusted, comprehensive information about this skin condition.

Until about 20 years ago, systemic treatment options for moderate/severe psoriasis were limited and nonspecific. To get an idea of how much the field has changed, clinical guidelines on psoriasis ...

SFA Therapeutics, Inc. has announced encouraging results from its Phase 1b clinical trial of SFA-002, an oral drug candidate aimed at treating mild-to-moderate psoriasis. The study demonstrated both ...

The patient-years of exposure in the study amounted to 5,000, Charles added, suggesting Sotyktu is safe to use as a long-term treatment for moderate to severe plaque psoriasis.

For patients with moderate-to-severe plaque psoriasis, ixekizumab is effective and safe, with induction therapy ... as a therapeutic option, even in treatment-experienced populations." ...

Psoriasis on the hands and feet can make everyday activities difficult. Treatment typically begins with moisturisers and vitamin-D or steroid creams. If these don’t prove effective, patients may ...

Janus kinase inhibitors (JAKis) are an important treatment option for people with chronic inflammatory diseases such as rheumatoid arthritis, psoriasis, Crohn's disease or ulcerative colitis.